Chinese Biotechs' Foray Into mRNA Enters New Chapter With $100m Everest Deal

 
• By Dexter Jie Yan

Everest Medicines’ deal with Canadian biotech Providence Therapeutics contains a full transfer of technology which may be appealing to Chinese regulators.

Chinese biotechs foray into mRNA
Everest the latest Chinese biotech to leap into mRNA fray • Source: Alamy

More from China

More from Focus On Asia